This is a preview of subscription content, access via your institution
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Packman W, Weber S, Wallace J, Bugescu N . Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review. Bone Marrow Transplant 2010; 45: 1134–1146.
Sanders JE, Hoffmeister PA, Storer BE, Applebaum FR, Storb RF, Syrjala KL . The quality of life of adult survivors of childhood hematopoietic cell transplant. Bone Marrow Transplant 2010; 45: 746–754.
Leung W, Hudson MM, Strickland DK, Phipps S, Srivastava DK, Ribeiro RC et al. Late effects of treatment in survivors of childhood acute myeloid leukemia. J Clin Oncol 2000; 18: 3273–3279.
Meeske KA, Siegel SE, Globe DR, Mack WJ, Bernstein L . Prevalence and correlates of fatigue in long-term survivors of childhood leukemia. J Clin Oncol 2005; 23: 5501–5510.
Zeltzer LK, Lu Q, Leisenring W, Tsao JCI, Recklitis C, Armstrong G et al. Psychosocial outcomes and health-related qualtiy of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev 2008; 17: 435–446.
Michel G, Rebholz CE, von der Weid NX, Bergstraesser E, Kuehni CE . Psychological distress in adult survivors of childhood cancer: the Swiss Childhood Cancer Survivor study. J Clin Oncol 2010; 28: 1740–1748.
Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007; 40: 219–224.
Sun CL, Francisco L, Baker KS, Weisdorf DJ, Forman SJ, Bhatia S . Adverse psychological outcomes in long-term survivors of hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study (BMTSS). Blood 2011; 118: 4723–4731.
Brinkman TM, Ullrich NJ, Zhang N, Green DM, Zeltzer LK, Lommel KM et al. Prevalence and predictors of prescription psychoactive medication use in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Cancer Surviv 2013; 7: 104–114.
Deyell RJ, Lorenzi M, Ma S, Rassekh SR, Collet JP, Spinelli JJ et al. Antidepressant use among survivors of childhood, adolescent and young adult cancer: a report of the Childhood, Adolescent and Young Adult Cancer Survivor (CAYACS) Research Program. Pediatr Blood Cancer 2013; 60: 816–822.
Khera N, Storer B, Flowers ME, Carpenter PA, Inamoto Y, Sandmaier BM et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. J Clin Oncol 2012; 30: 71–77.
Compton WM, Conway KP, Stinson FS, Grant BF . Changes in the prevalence of major depression and comorbid substance use disorders in the United States between 1991-1992 and 2001-2002. Am J Psychiatry 2006; 163: 2141–2147.
Perou R, Bitsko RH, Blumberg SJ, Pastor P, Ghandour RM, Gfroerer JC et al. Mental health surveillance among children—United States, 2005-2011. MMWR Surveill Summ 2013; 62: 1–35.
Kazak AE, Derosa BW, Schwartz LA, Hobbie W, Carlson C, Ittenbach RF et al. Psychological outcomes and health beliefs in adolescent and young adult survivors of childhood cancer and controls. J Clin Oncol 2010; 28: 2002–2007.
Simon GE, Von KM, Saunders K, Miglioretti DL, Crane PK, van BG et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006; 63: 824–830.
Supported in part by the National Cancer Institute (CA 018029, HL 36444, CA 15704, CA 160684 and CA 78902). We are thankful to the FHCRC Long-term Follow-up staff and to our patients and their physicians who participate in our long-term follow-up program.
The authors declare no conflict of interest.
About this article
Cite this article
Hoffmeister, P., Storer, B., Syrjala, K. et al. Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up. Bone Marrow Transplant 51, 153–156 (2016). https://doi.org/10.1038/bmt.2015.233